# Liraglutide Hospital Discharge Trial

> **NCT01919489** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 273 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Liraglutide + OADs
- **DRUG:** Glargine + OADs

## Key facts

- **NCT ID:** NCT01919489
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2021-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01919489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01919489, "Liraglutide Hospital Discharge Trial". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01919489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*